ST14A cells have properties of a medium-size spiny neuron.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Experimental Neurology

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXNR.2000.7551PMID 11161610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sodium ionic and gating currents in mammalian cells

  2004cited by this paper
• Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3

  2000cited by this paper
• Gene therapy of experimental brain tumors using neural progenitor cells

  2000cited by this paper
• Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos

  1999cited by this paper
• Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.

  1999cited by this paper
• Immortalized Human Dorsal Root Ganglion Cells Differentiate into Neurons with Nociceptive Properties

  1999cited by this paper
• Expression of the Striatal DARPP-32/ARPP-21 Phenotype in GABAergic Neurons Requires Neurotrophins In Vivo andIn Vitro

  1999cited by this paper
• D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons.

  1999cited by this paper
• Functional changes in potassium conductances of the human neuroblastoma cell line SH-SY5Y during in vitro differentiation.

  1998cited by this paper
• Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen.

  1998cited by this paper
• Generation and characterization of embryonic striatal conditionally immortalized ST14A cells

  1998cited by this paper
• Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro.

  1997cited by this paper
• Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain.

  1997cited by this paper
• Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum.

  1997cited by this paper
• Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons

  1996cited by this paper
• Delivery of newly synthesized tubulin to rapidly growing distal axons of sympathetic neurons in compartmented cultures

  1996cited by this paper
• Functional changes in sodium conductances in the human neuroblastoma cell line SH-SY5Y during in vitro differentiation.

  1996cited by this paper
• Intracerebral tetracycline-dependent regulation of gene expression in grafts of neural precursors.

  1996cited by this paper
• Activation of the JAK/STAT Pathway Leads to Proliferation of ST14A Central Nervous System Progenitor Cells*

  1996cited by this paper
• Immortalized murine striatal neuronal cell lines expressing dopamine receptors and cholinergic properties

  1995cited by this paper
• Novel expression of the tyrosine hydroxylase gene requires both acidic fibroblast growth factor and an activator

  1994cited by this paper
• Multiple effects of protein kinase C activators on Na+ currents in mouse neuroblastoma cells

  1994cited by this paper
• Isolation and characterization of conditionally immortalized astrocyte cell lines derived from adult human spinal cord

  1994cited by this paper
• Developmental changes in Gs and G(olf) proteins and adenylyl cyclases in mouse brain membranes.

  1994cited by this paper
• Tetrodotoxin-resistant sodium channels

  1994cited by this paper
• 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.

  1994cited by this paper
• A short term analysis of the behaviour of conditionally immortalized neuronal progenitors and primary neuroepithelial cells implanted into the fetal rat brain.

  1994cited by this paper
• Immortalized GABAergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV40 large T antigen.

  1993cited by this paper
• Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe.

  1993cited by this paper
• Chronic repeated cocaine administration alters basal and opioid‐regulated adenylyl cyclase activity

  1993cited by this paper
• Immortalization of raphe neurons: an approach to neuronal function in vitro and in vivo.

  1992cited by this paper
• An oligodendrocyte precursor cell line from rat optic nerve.

  1992cited by this paper
• Multipotent neural cell lines can engraft and participate in development of mouse cerebellum.

  1992cited by this paper
• Differentiation and heterogeneity in T‐antigen immortalized precursor cell lines from mouse cerebellum

  1991cited by this paper
• Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain.

  1991cited by this paper
• DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra.

  1990cited by this paper
• Neurotransmitters and neuromodulators in the basal ganglia.

  1990cited by this paper
• Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer.

  1990cited by this paper
• ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine- innervated brain regions. II. Immunocytochemical localization in rat brain

  1989cited by this paper
• Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature

  1989cited by this paper
• Immortalization of precursor cells from the mammalian CNS.

  1988cited by this paper
• Ontogeny of the dopamine and cyclic adenosine‐3′: 5′ ‐monophosphate‐regulated phosphoprotein (DARPP‐32) in the pre‐ and postnatal mouse central nervous system

  1988cited by this paper
• Prenatal ontogeny of the GABAergic system in the rat brain: an immunocytochemical study.

  1986cited by this paper
• Early development of voltage-dependent sodium currents in cultured mouse spinal cord neurons.

  1986cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper

• Regulation of the structural dynamics, aggregation, and pathogenicity of polyQ-expanded Huntingtin by osmolytes.

  2025cites this paper
• Speech- and language-linked FOXP2 mutation targets protein motors in striatal neurons.

  2023cites this paper
• Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins

  2022cites this paper
• P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease

  2021cites this paper
• Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model

  2021cites this paper
• Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin

  2020cites this paper
• Melanocortin 4 receptor activation protects striatal neurons and glial cells from 3‐nitropropionic acid toxicity

  2019influential citation
• Elevated intracellular cAMP concentration mediates growth suppression in glioma cells

  2019cites this paper
• Characterization of ST 14 A Cells for Studying Modulation of Voltage-Gated Calcium Channels

  2017influential citation
• Necroptosis in neurodegenerative diseases: a potential therapeutic target

  2017cites this paper
• KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients

  2017cites this paper
• Immunotherapy on Experimental Models for Huntington’s Disease

  2016cites this paper
• Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ

  2016cites this paper
• SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models

  2016influential citation
• SIRT 2-and NRF 2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington ’ s Disease Models Highlights

  2016influential citation
• Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

  2016cites this paper
• SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models.

  2016influential citation
• Investigating developmental and functional deficits in neurodegenerative disease using transcriptomic analyses

  2016cites this paper
• Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors.

  2015cites this paper
• Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium Channels

  2015influential citation
• A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease

  2015cites this paper
• Lysosomal storage disorders and neurodegenerative disease; related mechanisms of pathogenesis and identification of novel therapeutic targets

  2015cites this paper
• Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.

  2014cites this paper
• Inhibition of mitochondrial protein import by mutant huntingtin

  2014cites this paper
• AAV-Dominant Negative Tumor Necrosis Factor (DN-TNF) Gene Transfer to the Striatum Does Not Rescue Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease

  2014cites this paper
• Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease

  2014cites this paper
• BDNF prevents NMDA‐induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved

  2013cites this paper
• The A2A Adenosine Receptor Is a Dual Coding Gene

  2013cites this paper
• Intrabodies as Neuroprotective Therapeutics

  2013cites this paper
• Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease.

  2013cites this paper
• Studying neurodegenerative diseases in culture models.

  2013cites this paper
• Neural Stem/Progenitor Cell Clones as Models for Neural Development and Transplantation

  2012cites this paper
• Huntington’s Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease

  2012cites this paper
• Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons

  2012cites this paper
• Spt4 is selectively required for transcription of extended trinucleotide repeats.

  2012influential citation
• Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons.

  2012cites this paper
• Regulation of Feedback between Protein Kinase A and the Proteasome System Worsens Huntington's Disease

  2012cites this paper
• Molecular biology of Huntington's disease.

  2011cites this paper
• Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments

  2011cites this paper
• Post-translational myristoylation during cell death

  2011cites this paper
• Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease

  2011cites this paper
• Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.

  2010cites this paper
• Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma.

  2010cites this paper
• Evaluation of Histone Deacetylases as Drug Targets in Huntington’s Disease models

  2010cites this paper
• Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicity in Vitro*

  2009cites this paper
• Phosphorylation of Threonine 3

  2009cites this paper
• Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity

  2009cites this paper
• Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus.

  2008cites this paper
• β‐Catenin and actin reorganization in HGF/SF response of ST14A cells

  2008cites this paper
• In Vitro Characterization of Embryionic ST14A-Cells

  2008cites this paper
• Novel and immortalization-based protocols for the generation of neural CNS stem cell lines for gene therapy approaches.

  2008cites this paper
• Specific properties of sodium currents in multipotent striatal progenitor cells

  2008influential citation
• An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity.

  2008cites this paper
• Establishment of an immortalized GABAergic neuronal progenitor cell line from embryonic ventral mesencephalon in the rat.

  2008influential citation
• Role of huntingtin phosphorylation at serine 421 in Huntington Disease

  2007cites this paper
• Systematic Uncovering of Multiple Pathways Underlying the Pathology of Huntington Disease by an Acid-cleavable Isotope-coded Affinity Tag Approach*S

  2007cites this paper
• 2‐DE profiling of GDNF overexpression‐related proteome changes in differentiating ST14A rat progenitor cells

  2007cites this paper
• Wnt Signal Pathways and Neural Stem Cell Differentiation

  2006cites this paper
• Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation.

  2006cites this paper
• Characterization of Mouse Striatal Precursor Cell Lines Expressing Functional Dopamine Receptors

  2006cites this paper
• CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model

  2005cites this paper
• Functional significance of HCN2/3‐mediated Ih in striatal cells at early developmental stages

  2005influential citation
• A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's disease.

  2005cites this paper
• Wnt-5a expression in the rat neuronal progenitor cell line ST14A

  2004cites this paper
• ErbB4 Expression in Neural Progenitor Cells (ST14A) Is Necessary to Mediate Neuregulin-1β1-induced Migration*

  2004cites this paper
• Apoptosome inactivation rescues proneural and neural cells from neurodegeneration

  2004cites this paper
• Gene expression profiling of ciliary neurotrophic factor‐overexpressing rat striatal progenitor cells (ST14A) indicates improved stress response during the early stage of differentiation

  2003cites this paper
• Neural Stem Cells

  2003cites this paper
• Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A

  2003cites this paper
• Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

  2003cites this paper
• Gene Therapy for Parkinson’s Disease

  2002cites this paper
• Modeling brain pathologies using neural stem cells.

  2002cites this paper
• Large-scale sources of neural stem cells.

  2002cites this paper
• Gene therapy using neural stem cells.

  2002cites this paper
• Huntingtin's Neuroprotective Activity Occurs via Inhibition of Procaspase-9 Processing*

  2001cites this paper
• Characterization of a p75NTR Apoptotic Signaling Pathway Using a Novel Cellular Model*

  2001cites this paper
• Loss of normal huntingtin function: new developments in Huntington's disease research.

  2001cites this paper
• Modeling huntington’s disease in cells, flies, and mice

  2001cites this paper
• Disease in a dish : modeling Tau pathology for future antibody Disease in a dish : modeling Tau pathology for future antibody testing testing

  year unknowncites this paper
• Serine 421 regulates mutant huntingtin toxicity and clearance in mice

  year unknowncites this paper